Breaking the barriers to global gene delivery

Nature Biotechnology

Volumn 23, Issue 3, 2005, Pages 305-306

  Weitzman, Matthew D ^a   Thistlethwaite, Patricia A ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; VASCULOTROPIN; DNA;

ADENO ASSOCIATED VIRUS; GENE DELIVERY SYSTEM; GENETIC TRANSDUCTION; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHORT SURVEY; SKELETAL MUSCLE; TARGET ORGAN; VIRUS CAPSID; ADENOVIRUS; ANIMAL; DRUG DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; MUSCLE DISEASE; NOTE; PATHOPHYSIOLOGY;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; MIRIDAE;

ADENOVIRIDAE; ANIMALS; DNA; DRUG DELIVERY SYSTEMS; GENE TARGETING; GENE THERAPY; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; TRANSDUCTION, GENETIC;

EID: 21444435168     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0305-305     Document Type: Short Survey

References (10)

1. Wang, Z. et al. Nat. Biotechnol. 23, 321-328 (2005).
2. Xiao, X., Li, J. & Samulski, R.J. J. Virol. 70, 8098-8108 (1996).
3. Du, L. et al. Mol. Ther. 10, 604-608 (2004).
4. Hoshijima, M. et. al. Nat. Med. 8, 864-871 (2002)
5. Greelish, J.P. et al. Nat. Med. 5, 439-443 (1999).
6. Gregorevic, P. et al. Nat. Med. 10, 828-834 (2004).
7. Gao, G.P. et al. Proc. Natl. Acad. Sci. U S A 99, 11854-11859 (2002).
8. Rabinowitz, J.E. et al. J. Virol. 76, 791-801 (2002).
9. Blankinship, M.J. et al. Mol. Ther. 10, 671-678 (2004).
10. Kay, M.A. et al. Nat. Genet. 24, 257-261 (2000).